Zoclar 250mg (Clarithromycin)

Introduction

Zoclar 250mg is a macrolide antibiotic with an active ingredient Clarithromycin. Clarithromycin is an effective antibacterial drug that is utilized to treat a diverse variety of bacterial infections. Produced in accordance with strict standards for pharmaceuticals, Zoclar offers a reliable and safe treatment option for those with respiratory, skin, and other bacterial infections. The broad spectrum of its activity is a popular treatment option for physicians within both hospital and outpatient settings.

Clarithromycin is part of the macrolide antibiotic class, well-known for its bacteriostatic mechanisms of action. It is primarily used to inhibit the synthesis of proteins in bacteria. Zoclar 250mg provides specific relief through the elimination of pathogens responsible for infection without affecting healthy cells.

Composition

• Active Ingredient: Clarithromycin
• Strength: 250 mg per tablet
• Form: Film-coated tablet
• Packaging: Typically available in blister packs of 4 tablets

Pharmacological Class

• Therapeutic Class: Macrolide Antibiotic
• ATC Code: J01FA09

Mechanism of Action

Clarithromycin blocks the synthesis of proteins by bacterial cells through its attachment to the 50S ribosomal subunit of microorganisms that are susceptible. The action blocks the transfer of peptides, thus stopping the growth of bacteria and reproduction. This is principally bacteriostatic and can also show bactericidal action at higher levels against particular varieties.

Clarithromycin can be powerful against many Gram-positive and Gram-negative bacteria and also against uncommon organisms, such as Mycoplasma pneumoniae and Chlamydia pneumoniae.

Indications and Usage

Zoclar 250mg is recommended to treat a variety of bacteria-related infections that are caused by susceptible organisms. These include:

1. Respiratory Tract Infections

• Acute and chronic bronchitis
• Community-acquired pneumonia
• Pharyngitis and tonsillitis (caused by Streptococcus pyogenes)
• Sinusitis

2. Skin and Soft Tissue Infections

• Cellulitis
• Folliculitis
• Erysipelas
• Impetigo

3. Mycobacterial Infections

• Disseminated Mycobacterium avium complex (MAC) infections in HIV-infected patients

4. Helicobacter pylori Eradication

• A part of the treatment for the condition known as a peptic ulcer

5. Otitis Media

• Especially in pediatric populations (formulation may vary)

Dosage and Administration

The dose of Zoclar 250mg is based on the severity and type of the infection, and also on the patient’s age, weight, and kidney function.

Adults and Adolescents (≥12 years)

• Typical Dose: 250 mg every 12 hours for 7 to 14 days
• Severe Infections: May require up to 500 mg every 12 hours

Helicobacter pylori Treatment (Triple Therapy)

• Clarithromycin 500 mg twice daily + a proton pump inhibitor + another antibiotic (usually amoxicillin or metronidazole) for 7–14 days

Mycobacterial Infections

• Initial dose: 500 mg twice daily
• Duration: As directed by a specialist, often long-term therapy

Pediatric Use

• In the case of children younger than 12, formulations for liquid suspensions tend to be preferable. Dosage calculation is according to body weight.

Renal Impairment

• A dose adjustment is advised for patients who have a creatinine clearance of <30 mL/min.

Contraindications

Zoclar (Clarithromycin) is contraindicated for the following reasons:

• A known hypersensitivity to Clarithromycin, erythromycin, and other macrolide antibiotics
• The use of drugs in combination with each other by CYP3A4 could result in serious adverse reactions (e.g., astemizole, cisapride, pimozide, terfenadine)
• Patients who have a history of QT lengthening or ventricular cardiac arrhythmia
• A severe hepatic impairment with renal impairment
• Colchicine is a co-intoxicant in patients who suffer from hepatic or renal dysfunction

Precautions and Warnings

• QT Prolongation: Patients with medical conditions that affect the heart or electrolyte imbalances.
• Hepatotoxicity: Monitor the function of your liver during long-term treatment.
• Superinfection: In the long run, prolonged use could lead to superinfections caused by fungi or bacteria (e.g., C. difficile-associated diarrhea).
• Renal Impairment: Requires dosage adjustment.
• Use in Pregnancy: Category C is only used in cases where the benefits are greater than the risks.
• Lactation: Clarithromycin is excreted in human milk. It is recommended to take care.

Drug Interactions

Clarithromycin is an effective inhibitor of CYP3A4 and could be a drug interaction with a variety of drugs:

• Warfarin: Anticoagulant effects are enhanced
• Statins (e.g., simvastatin, lovastatin): The risk of myopathy and Rhabdomyolysis
• Theophylline, carbamazepine, digoxin: Increased plasma levels
• Oral hypoglycemics/insulin: Risk of hypoglycemia
• Ergot alkaloids: Risk of ergot toxicity

Always speak with a doctor before mixing Zoclar and other medications.

Adverse Reactions

Common side effects include:

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain, dyspepsia
• Neurological: Headache, dizziness, taste alteration
• Hepatic: Elevated liver enzymes, hepatitis (rare)
• Dermatological: Rash, itching, urticaria
• Other: Oral candidiasis, photosensitivity

Serious but rare reactions:

• Stevens-Johnson syndrome
• Anaphylaxis
• Pseudomembranous colitis
• Hepatic failure

Pharmacokinetics

• Absorption: Absorbs quickly; bioavailability around 55%
• Peak Plasma Levels: Within a couple of hours following oral administration
• Distribution: In the body, it is widely distributed. High concentrations of it in the lung tissue, as well as the middle ear fluid
• Metabolism: Hepatic via CYP3A4 to active metabolite 14-hydroxyclarithromycin
• Half-Life: 3–7 hours depending on dose
• Excretion: Most commonly, it is through Feces and urine

Storage Instructions

• Store below 25°C (77°F)
• Beware of moisture, direct sunlight, and children
• Don’t use the pack after the expiry dates printed on the packaging

Availability

Zoclar 250mg is a prescribed medicine (Rx) and is sold at:

• Blister packs of 4 tablets
• Also available in 500 mg strength and pediatric suspensions

Brand and Manufacturer Information

Brand Name: Zoclar
Generic Name: Clarithromycin
Strength: 250mg
Pharmaceutical Form: Film-coated tablet
Manufacturer: Cipla Limited

Conclusion

Zoclar 250mg (Clarithromycin) is a dependable and efficient macrolide antibiotic that is used worldwide to treat the respiratory tract, skin, and a variety of gastrointestinal diseases. Proven efficacy, solid safety record, and a wide-spectrum coverage, Zoclar is the first choice for controlling bacterial infections across a range of population groups of patients.

Similar to all antibiotics, Zoclar must be administered with care in order to avoid resistance. Make sure you complete the entire regimen of treatment, and talk to your doctor for the correct treatment and dosage suggestions.